
Oncology NEWS International
- Oncology NEWS International Vol 7 No 11
- Volume 7
- Issue 11
RTOG to Conduct Multicenter Study of Prostate Brachytherapy
PHILADELPHIA--The Radiation Therapy Oncology Group (RTOG) has just begun work on a potentially ground-breaking study of the use of radioactive seed implants (brachytherapy) for cancer that is confined to the prostate gland. The study will be the first multi-institutional evaluation of the treatment. To date, a number of single-institution studies have been conducted, showing the technique to be effective in controlling the disease.
PHILADELPHIA--The Radiation Therapy Oncology Group (RTOG) has just begun work on a potentially ground-breaking study of the use of radioactive seed implants (brachytherapy) for cancer that is confined to the prostate gland. The study will be the first multi-institutional evaluation of the treatment. To date, a number of single-institution studies have been conducted, showing the technique to be effective in controlling the disease.
The new RTOG investigation will look closely at the potential side effects of prostate brachytherapy as well as its effectiveness, said Colleen Lawton, MD, study chair. Dr. Lawton is a radiation oncologist at the Medical College of Wisconsin, Milwaukee.
Articles in this issue
over 27 years ago
Vinorelbine/Cisplatin Improves Survival In Advanced NSCLCover 27 years ago
Centers Selected for STAR, Study of Tamoxifen and Raloxifeneover 27 years ago
HDC/PBSC for Advanced Breast Cancer Debatedover 27 years ago
New Programs Aim to Improve Home Care Servicesover 27 years ago
Breast Cancer Patients Sought for Study of Premature Menopauseover 27 years ago
Study Update Shows Improved Survival With Anastrozoleover 27 years ago
New Colon Cancer Mouse Model First to Mimic Human Diseaseover 27 years ago
Best Use of Breast Cancer Genetics Presents Clinical Challengeover 27 years ago
Families Share Pleasure and Pain at The Marchover 27 years ago
Panel Lists 13 Areas for Emphasis in NCI Breast Cancer ResearchNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



































